Arca
Skip to content
Tools
Tools

Phosphate

Small molecule in Homo sapiens that 8 drugs act on.

  • Drugs that act on it: 8
  • Approved: 6
  • In phases 1 to 3: 2
  • Sponsors: 6

Who is on it, and how far along

Every drug ChEMBL records acting on this target, by the furthest stage it has reached for any use, coloured by modality.

How to read this

Each mark is one drug. Columns run from approved to phase 1; hover or tap a mark for its sponsor, modality and open trials, and click it to open the drug.

  • Small molecule 7
  • Other 1

Approved6

  • Calcium acetate
  • Lanthanum carbonate
  • Sevelamer hydrochloride
  • Colestilan chloride
  • Ferric citrate anhydrous
  • Ferric oxyhydroxide

Phase 32

  • Bixalomer
  • Fermagate

Phase 20

    Phase 10

      Sponsors

      Drugs on this target per company: the US application holder, else the industry sponsor leading the most of its trials.

      The landscape

      Every drug acting on it, furthest along first. The sponsor is the US application holder where there is one, else the industry lead sponsor of most of its registered trials. All act as: Phosphate sequestering agent.
      Calcium acetateApproved—Small moleculeSequestering agent79
      Lanthanum carbonateApprovedTakeda Pharmaceuticals USASmall moleculeSequestering agent1
      Sevelamer hydrochlorideApprovedSanofiSmall moleculeSequestering agent1
      Colestilan chlorideApprovedTanabe Pharma CorporationSmall moleculeSequestering agent0
      Ferric citrate anhydrousApprovedPanion & BF BiotechSmall moleculeSequestering agent0
      Ferric oxyhydroxideApprovedVifor Fresenius Medical Care Renal PharmaSmall moleculeSequestering agent0
      BixalomerPhase 3—Small moleculeSequestering agent0
      FermagatePhase 3Ineos Healthcare LimitedOtherSequestering agent0

      Open trials

      The most recently posted recruiting or ongoing trials naming each drug (up to 8 a drug), 10 in all, from ClinicalTrials.gov.
      Asciminib-Based Induction Therapy for the Treatment of Newly Diagnosed Philadelphia Chromosome-Positive Acute Lymphoblastic LeukemiaCalcium acetatePhase 1Not yet recruitingCity of Hope Medical CenterNov 3, 2026
      Tenapanor in Maintenance Hemodialysis PatientsLanthanum carbonate—Not yet recruitingHuashan HospitalOct 20, 2026
      Testing the Use of High Dose Testosterone Followed by Darolutamide Compared to the Usual Care for Patients With Metastatic Prostate CancerCalcium acetatePhase 2 / Phase 3Not yet recruitingECOG-ACRIN Cancer Research GroupOct 1, 2026
      FPS-ZM1 With or Without Dexamethasone for Controlling Post Operative Cerebral Edema in Patients With GlioblastomaCalcium acetatePhase 1Not yet recruitingCity of Hope Medical CenterAug 27, 2026
      Time to First Rescue Antiemetic With Ondansetron Plus Metoclopramide Versus Dexamethasone Plus Metoclopramide for PONV Prophylaxis in Laparoscopic CholecystectomyCalcium acetatePhase 4RecruitingFaisalabad Medical UniversityJun 10, 2026
      Testing Blinatumomab With or Without Revumenib in Patients With B-cell Acute Lymphoblastic Leukemia With a Genetic Change Requiring More TreatmentCalcium acetatePhase 2Not yet recruitingSWOG Cancer Research NetworkJun 9, 2026
      Testing an Experimental Approach to Treat Patients With Plasma Cell Leukemia, The QUANTUM TrialCalcium acetatePhase 2RecruitingNational Cancer Institute (NCI)May 26, 2026
      Impact of Medically Supervised Performance-Enhancing Substances (PES) on Elite AthletesCalcium acetateNot applicableEnrolling by invitationEnhanced Emirates LimitedMay 6, 2026
      Testing the Investigational Medication Combination of Teclistamab and Pomalidomide Compared to the Usual Treatment (Carfilzomib, Pomalidomide, and Dexamethasone) for Patients With Multiple Myeloma Who Have Relapsed Shortly After TreatmentCalcium acetatePhase 1 / Phase 2RecruitingNational Cancer Institute (NCI)Mar 11, 2026
      Pharmacokinetics, Pharmacodynamics, and Safety Profile of Understudied Drugs Administered to Children Per Standard of Care (POPS)Sevelamer hydrochloride—RecruitingDuke UniversityFeb 20, 2020

      Drugs, mechanisms, furthest stage (max phase) and modality (molecule type) are from ChEMBL CHEMBL2364184, ChEMBL 37, fetched 2026-11-18 (CC BY-SA 3.0). Sponsors are the US application holder (Drugs@FDA) for approved drugs with a US page, else the industry lead sponsor of the most of the drug's ClinicalTrials.gov trials. Open trials are recruiting or ongoing studies naming the drug as an intervention on ClinicalTrials.gov, checked daily; this page as of 2026-11-21. ChEMBL and Open Targets

      Esc

      Type a name: a tool, a company, a drug or brand, a condition, a gene or a state. Identifiers like K231234, NCT05012345 or NDA 215866 open their record.

      Logos are each company's own site icon, matched by name through Wikidata, or logos provided by Logo.dev.Company names and logos identify the companies in public FDA and registry records and do not imply endorsement.